Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Satgé

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Medical Hypotheses|June 2, 2014
Are GATA1 mutations occurring at random in Down syndrome transient leukemia?Daniel Satgé
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|November 25, 2011
On somatic mutations and tissue fields in cancer: additional observations challenge the SMTDaniel Satgé
Frontiers in Immunology|June 9, 2018
A Tumor Profile in Primary Immune Deficiencies Challenges the Cancer Immune Surveillance ConceptDaniel Satgé
Ophthalmic Genetics|November 28, 2009
Are patients with down syndrome predisposed to retinal neoplasms?Daniel Satgé
Journal of Medical Screening|October 27, 2022
Age at breast cancer screening in women with intellectual disabilityDaniel Satgé, Motoi Nishi
Clinical Genetics|February 8, 2011
Down syndrome patients are less likely to develop some (but not all) malignant solid tumoursDaniel Satgé, Michel Vekemans
Seminars in Cancer Biology|May 6, 2008
Carcinogenesis in Down syndrome: what can be learned from trisomy 21?Daniel Satgé, Jean Bénard
Cancers|March 13, 2025
Ovarian Cancer in Women with Intellectual Disability: Current DataBrigitte Trétarre, Daniel Satgé
BMJ (Clinical Research Ed.)|May 11, 2002
Breast screening guidelines should be adapted in Down's syndromeDaniel Satgé, Annie J Sasco
Frontiers in Immunology|January 12, 2019
The Pattern of Malignancies in Down Syndrome and Its Potential Context With the Immune SystemDaniel Satgé, Markus G Seidel
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Medical Hypotheses|June 2, 2014
Are GATA1 mutations occurring at random in Down syndrome transient leukemia?Daniel Satgé
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|November 25, 2011
On somatic mutations and tissue fields in cancer: additional observations challenge the SMTDaniel Satgé
Frontiers in Immunology|June 9, 2018
A Tumor Profile in Primary Immune Deficiencies Challenges the Cancer Immune Surveillance ConceptDaniel Satgé
Ophthalmic Genetics|November 28, 2009
Are patients with down syndrome predisposed to retinal neoplasms?Daniel Satgé
Journal of Medical Screening|October 27, 2022
Age at breast cancer screening in women with intellectual disabilityDaniel Satgé, Motoi Nishi
Clinical Genetics|February 8, 2011
Down syndrome patients are less likely to develop some (but not all) malignant solid tumoursDaniel Satgé, Michel Vekemans
Seminars in Cancer Biology|May 6, 2008
Carcinogenesis in Down syndrome: what can be learned from trisomy 21?Daniel Satgé, Jean Bénard
Cancers|March 13, 2025
Ovarian Cancer in Women with Intellectual Disability: Current DataBrigitte Trétarre, Daniel Satgé
BMJ (Clinical Research Ed.)|May 11, 2002
Breast screening guidelines should be adapted in Down's syndromeDaniel Satgé, Annie J Sasco
Frontiers in Immunology|January 12, 2019
The Pattern of Malignancies in Down Syndrome and Its Potential Context With the Immune SystemDaniel Satgé, Markus G Seidel
Pageof 4